Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1970 Jan 17;1(5689):149–152. doi: 10.1136/bmj.1.5689.149

Effects of Obesity, Glucocorticoid, and Oral Contraceptive Therapy on Plasma Glucose and Blood Pyruvate Levels

J W H Doar, Victor Wynn
PMCID: PMC1699069  PMID: 5413954

Abstract

The plasma glucose and blood pyruvate levels were determined after oral glucose tolerance test in six groups of women: non-obese and obese controls and in non-obese and obese women receiving glucocorticoid or oral contraceptive therapy. The mean fasting plasma glucose level was similar in all groups, but glucose tolerance was impaired in the obese controls, non-obese women on oral contraceptives or being treated with glucocorticoids, and appreciably impaired in the obese oral contraceptive and glucocorticoid groups compared with mean levels in non-obese subjects of the same groups. Obesity was associated with abnormally raised blood pyruvate levels in response to a glucose tolerance test in all groups. Striking similarities were observed between the responses of the plasma glucose and blood pyruvate levels to glucose tolerance tests in the obese control and non-obese oral contraceptive and non-obese glucocorticoid-treated groups. It is suggested that these abnormalities result from a common mechanism—namely, glucocorticoid excess.

Full text

PDF
149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cramp D. G. New automated method for measuring glucose by glucose oxidase. J Clin Pathol. 1967 Nov;20(6):910–912. doi: 10.1136/jcp.20.6.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doar J. W., Wynn V., Cramp D. G. Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women. Metabolism. 1968 Aug;17(8):690–701. doi: 10.1016/0026-0495(68)90053-x. [DOI] [PubMed] [Google Scholar]
  3. GERSHBERG H., JAVIER Z., HULSE M. GLUCOSE TOLERANCE IN WOMEN RECEIVING AN OVULATORY SUPPRESSANT. Diabetes. 1964 Jul-Aug;13:378–382. doi: 10.2337/diab.13.4.378. [DOI] [PubMed] [Google Scholar]
  4. Goldman J. A., Ovadia J. L., Eckerling B. Effect of progesterone on glucose tolerance in women. Isr J Med Sci. 1968 Jul-Aug;4(4):878–882. [PubMed] [Google Scholar]
  5. Goldman J. A., Ovadia J. L. The effect of estrogen on intravenous glucose tolerance in woman. Am J Obstet Gynecol. 1969 Jan 15;103(2):172–178. doi: 10.1016/s0002-9378(16)34385-x. [DOI] [PubMed] [Google Scholar]
  6. Javier Z., Gershberg H., Hulse M. Ovulatory suppressants, estrogens, and carbohydrate metabolism. Metabolism. 1968 May;17(5):443–456. doi: 10.1016/0026-0495(68)90067-x. [DOI] [PubMed] [Google Scholar]
  7. Keller N., Richardson U. I., Yates F. E. Protein binding and the biological activity of corticosteroids: in vivo induction of hepatic and pancreatic alanine aminotransferases by corticosteroids in normal and estrogen-treated rats. Endocrinology. 1969 Jan;84(1):49–62. doi: 10.1210/endo-84-1-49. [DOI] [PubMed] [Google Scholar]
  8. Matsui N., Plager J. E. In vitro physiological activity of protein-bound and unbound cortisol. Endocrinology. 1966 Jun;78(6):1159–1164. doi: 10.1210/endo-78-6-1159. [DOI] [PubMed] [Google Scholar]
  9. Perley M., Kipnis D. M. Effect of glucocorticoids on plasma insulin. N Engl J Med. 1966 Jun 2;274(22):1237–1241. doi: 10.1056/NEJM196606022742205. [DOI] [PubMed] [Google Scholar]
  10. Perley M., Kipnis D. M. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes. 1966 Dec;15(12):867–874. doi: 10.2337/diab.15.12.867. [DOI] [PubMed] [Google Scholar]
  11. Posner N. A., Silverstone F. A., Pomerance W., Baumgold D. Oral contraceptives and intravenous glucose tolerance. I. Data noted early in treatment. Obstet Gynecol. 1967 Jan;29(1):79–86. [PubMed] [Google Scholar]
  12. Posner N. A., Silverstone F. A., Pomerance W., Singer N. Oral contraceptives and intravenous glucose tolerance. II. Long-term effect. Obstet Gynecol. 1967 Jan;29(1):87–92. [PubMed] [Google Scholar]
  13. Schteingart D. E., Conn J. W. Characteristics of the increased adrenocortical function observed in many obese patients. Ann N Y Acad Sci. 1965 Oct 8;131(1):388–403. doi: 10.1111/j.1749-6632.1965.tb34805.x. [DOI] [PubMed] [Google Scholar]
  14. Wynn V., Doar J. W. Some effects of oral contraceptives on carbohydrate metabolism. Lancet. 1966 Oct 1;2(7466):715–719. doi: 10.1016/s0140-6736(66)92978-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES